|
BZW2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63136171238421E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92068583260152E-14 |
| Normal-vs-Stage2 |
4.83949999996458E-06 |
| Normal-vs-Stage3 |
2.35550468019596E-11 |
| Normal-vs-Stage4 |
6.4137029021083E-11 |
| Stage1-vs-Stage2 |
4.441200E-01 |
| Stage1-vs-Stage3 |
5.484200E-01 |
| Stage1-vs-Stage4 |
3.143400E-01 |
| Stage2-vs-Stage3 |
2.749400E-01 |
| Stage2-vs-Stage4 |
1.764600E-01 |
| Stage3-vs-Stage4 |
6.472800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.43769498715119E-15 |
| Normal-vs-AfricanAmerican |
7.004000E-04 |
| Normal-vs-Asian |
4.13225009765483E-12 |
| Caucasian-vs-AfricanAmerican |
1.925150E-01 |
| Caucasian-vs-Asian |
2.088800E-01 |
| AfricanAmerican-vs-Asian |
1.119180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.13062942025999E-12 |
| Normal-vs-Female |
1.67799107941846E-12 |
| Male-vs-Female |
9.612400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.59938770297686E-12 |
| Normal-vs-Age(41-60Yrs) |
7.43849426498855E-15 |
| Normal-vs-Age(61-80Yrs) |
1.72220000482781E-08 |
| Normal-vs-Age(81-100Yrs) |
5.027500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.087170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.803600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.872600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.939350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.576000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.489600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.455400E-01 |
| Classical-VS-Follicular |
7.400000E-02 |
| Classical-VS-Other |
8.352000E-01 |
| Classical-VS-Normal |
1.62658775337832E-12 |
| Tall-VS-Follicular |
5.789800E-02 |
| Tall-VS-Other |
5.924200E-01 |
| Tall-VS-Normal |
1.99260052902162E-10 |
| Follicular-VS-Other |
6.860800E-01 |
| Follicular-VS-Normal |
4.26760000005189E-06 |
| Other-VS-Normal |
4.663800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43041175862891E-13 |
| Normal-vs-N1 |
9.52349976657274E-10 |
| N0-vs-N1 |
4.200000E-01 |
|
|
